Preeclampsia and intrauterine growth restriction

The Endometrium: Molecular, Cellular and Clinical Perspectives, Second Edition

Volumn , Issue , 2008, Pages 745-760

  Heazell, Alexander E P ^a   Nugent, Justine ^a   Jones, Rebecca L ^a   Harris, Lynda K ^a   Baker, Philip N ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449085414     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (105)

1. Gardosi J, Kady SM et al. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 2005; 331(7525): 1113-17.
2. Confidential Enquiry into Maternal and Child Health. Why Mothers Die 2000-2002. London, RCOG Press, 2004.
3. Godfrey KM, Barker DJ. Fetal nutrition and adult disease. Am J Clin Nutr 2000; 71(Suppl 5): 1344S-52S.
4. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158(4): 892-8.
5. Sanderson DA, Wilcox MA et al. The individualised birthweight ratio: a new method of identifying intrauterine growth retardation. Br J Obstet Gynaecol 1994; 101(4): 310-14.
6. Myers JE, Brockelsby J. The epidemiology of pre-eclampsia. In: Barker PN, Kingdom JCP, eds. Pre-eclampsia: Current Perspectives on Management. London: Parthenon, 2004.
7. Bernstein PS, Divon MY. Etiologies of fetal growth restriction. Clin Obstet Gynaecol 1997; 40(4): 723-9.
8. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330(7491): 565.
9. Brar HS, Rutherford SE. Classification of intrauterine growth retardation. Semin Perinatol 1988; 12(1): 2-10.
10. Redline RW, Patterson P. Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol 1995; 26(6): 594-600.
11. Kwong WY, Wild AE et al. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development 2000; 127(19): 4195-202.
12. Rinaudo P, Schultz RM. Effects of embryo culture on global pattern of gene expression in preimplantation mouse embryos. Reproduction 2004; 128(3): 301-11.
13. Schieve LA, Meikle SF et al. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 2002; 346(10): 731-7.
14. Doherty AS, Mann MR et al. Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol Reprod 2000; 62(6): 1526-35.
15. Cross JC, Werb Z et al. Implantation and the placenta: key pieces of the development puzzle. Science 1994; 266(5190): 1508-18.
16. Lim H, Paria BC et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997; 91(2): 197-208.
17. Robb L, Li R et al. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 1998; 4(3): 303-8.
18. Brosens JJ, Pijnenborg R et al. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 2002; 187(5): 1416-23.
19. Golander A, Kopel R et al. Decreased prolactin secretion by decidual tissue of pre-eclampsia in vitro. Acta Endocrinol (Copenh) 1985; 108(1): 111-13.
20. Crossey PA, Pillai CC et al. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest 2002; 110(3): 411-18.
21. Giudice LC, Martina NA et al. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 1997; 176(4): 751-7; discussion 757-8.
22. Ribatti D, Loverro G et al. Expression of tenascin is related to angiogenesis in pre-eclampsia. Eur J Clin Invest 1998; 28(5): 373-8.
23. Wetzka B, Nusing R et al. Cyclooxygenase-1 and -2 in human placenta and placental bed after normal and pre-eclamptic pregnancies. Hum Reprod 1997; 12(10): 2313-20.
24. King A, Hiby SE et al. Recognition of trophoblast HLA class I molecules by decidual NK cell receptors - a review. Placenta 2000; 21 (Suppl A): S81-5.
25. Eide IP, Rolfseng T et al. Serious foetal growth restriction is associated with reduced proportions of natural killer cells in decidua basalis. Virchows Arch 2006; 448: 269-76.
26. Colbern GT, Chiang MH et al. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol 1994; 170(5 Pt 1): 1244-50.
27. Le Bouteiller P, Pizzato N et al. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 2003; 59(2): 219-34.
28. Wilczynski JR, Tchorzewski H et al. Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 109(1): 8-15.
29. Wegmann TG, Lin H et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14(7): 353-6.
30. Burk MR, Troeger C et al. Severely reduced presence of tissue macrophages in the basal plate of pre-eclamptic placentae. Placenta 2001; 22(4): 309-16.
31. Abrahams VM, Kim YM et al. Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol 2004; 51(4): 275-82.
32. Jeschke U, Mylonas I et al. Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. Oncol Rep 2005; 13(3): 413-19.
33. Caniggia I, Grisaru-Gravnosky S et al. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999; 103(12): 1641-50.
34. Caniggia I, Mostachfi H et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 2000; 105(5): 577-87.
35. Zhou Y, McMaster M et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002; 160(4): 1405-23.
36. Brosens I, Robertson WB et al. The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 1967; 93(2): 569-79.
37. Craven CM, Morgan T et al. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta 1998; 19(4): 241-52.
38. Pijnenborg R, Bland JM et al. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983; 4(4): 397-413.
39. Kam EP, Gardner L et al. The role of trophoblast in the physiological change in decidual spiral arteries. Hum Reprod 1999; 14(8): 2131-8.
40. Pijnenborg R, Dixon G et al. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980; 1(1): 3-19.
41. Kaufmann P, Black S et al. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69(1): 1-7.
42. Ashton SV, Whitley GS et al. Uterine spiral artery remodeling involves endothelial apoptosis induced by extravillous trophoblasts through Fas/FasL interactions. Arterioscler Thromb Vasc Biol 2005; 25(1): 102-8.
43. Harris LK, Keogh R, Wareing M et al. Invasive trophoblasts stimulate vascular smooth muscle cell apoptosis by a fas liganddependent mechanism. Am J Pathol 2006; 169: 1863-74.
44. Xu P, Wang Y et al. Effects of matrix proteins on the expression of matrix metalloproteinase-2, -9, and -14 and tissue inhibitors of metalloproteinases in human cytotrophoblast cells during the first trimester. Biol Reprod 2001; 65(1): 240-6.
45. De Falco M, Fedele V et al. Immunohistochemical distribution of proteins belonging to the receptor-mediated and the mitochondrial apoptotic pathways in human placenta during gestation. Cell Tissue Res 2004; 318(3): 599-608.
46. Kam DW, Charles AK et al. Caspase-14 expression in the human placenta. Reprod Biomed Online 2005; 11(2): 236-43.
47. Divya P, Chhikara P et al. Differential activity of cathepsin L in human placenta at two different stages of gestation. Placenta 2002; 23(1): 59-64.
48. Nakanishi T, Ozaki Y et al. Role of cathepsins and cystatins in patients with recurrent miscarriage. Mol Hum Reprod 2005; 11(5): 351-5.
49. Floridon C, Nielsen O et al. Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies. Placenta 1999; 20(8): 711-21.
50. Bauer S, Pollheimer J et al. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab 2004; 89(2): 812-22.
51. Benirschke K, Kaufmann P. Pathology of the Human Placenta. New York, Springer, 2000.
52. Khong TY, De Wolf F et al. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93(10): 1049-59.
53. Pijnenborg R, Anthony J et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98(7): 648-55.
54. Kadyrov M, Schmitz C et al. Pre-eclampsia and maternal anaemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. Placenta 2003; 24(5): 540-8.
55. Naicker T, Khedun SM et al. Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet Gynecol Scand 2003; 82(8): 722-9.
56. Meekins JW, Pijnenborg R et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994; 101(8): 669-74.
57. DiFederico E, Genbacev O et al. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999; 155(1): 293-301.
58. Reister F, Frank HG et al. The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta 1999; 20(2-3): 229-33.
59. Reister F, Frank HG et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001; 81(8): 1143-52.
60. Zhou Y, Fisher SJ et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997; 99(9): 2139-51.
61. Zhou Y, Damsky CH et al. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997; 99(9): 2152-64.
62. Graham CH, McCrae KR. Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients. Am J Obstet Gynecol 1996; 175(3 Pt 1): 555-62.
63. Iwaki T, Yamamoto K et al. Alteration of integrins under hypoxic stress in early placenta and choriocarcinoma cell line BeWo. Gynecol Obstet Invest 2004; 57(4): 196-203.
64. Staff AC, Ranheim T et al. Augmented PLA2 activity in preeclamptic decidual tissue - a key player in the pathophysiology of ‘acute atherosis’ in pre-eclampsia? Placenta 2003; 24(10): 965-73.
65. El-Hamedi A, Shillito J et al. A prospective analysis of the role of uterine artery Doppler waveform notching in the assessment of at-risk pregnancies. Hypertens Pregnancy 2005; 24(2): 137-45.
66. Prefumo F, Ayling LJ et al. Uterine artery resistance at 10-14 weeks of gestation is correlated with trophoblast apoptosis. Ultrasound Obstet Gynaecol 2004; 24: 234.
67. Wareing M, Myers JE et al. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab 2005; 90(5): 2550-5.
68. Wareing M, Myers JE et al. Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries. Am J Obstet Gynecol 2004; 190(5): 1283-90.
69. Nilsson H, Aalkjaer C. Vasomotion: mechanisms and physiological importance. Mol Interv 2003; 3(2): 79-89, 51.
70. Mayhew TM, Leach L et al. Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes). Placenta 1999; 20(5-6): 407-22.
71. Crocker IP, Daayana SL et al. An image analysis technique for the investigation of human placental morphology in preeclampsia and intrauterine growth restriction. J Soc Gynecol Invest 12004; 1(2(Suppl)): 347A.
72. Soma H, Yoshida K et al. Morphologic changes in the hypertensive placenta. Contrib Gynecol Obstet 1982; 9: 58-75.
73. Zhong XY, Holzgreve W et al. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002; 21(1): 77-83.
74. Macara L, Kingdom JC et al. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 1996; 17(1): 37-48.
75. Pardi G, Marconi AM et al. Placental-fetal interrelationship in IUGR fetuses - a review. Placenta 2002; 23(Suppl A): S136-41.
76. Smith SC, Baker PN et al. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 1997; 177(1): 57-65.
77. Smith SC, Baker PN et al. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997; 177(6): 1395-401.
78. Leung DN, Smith SC et al. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001; 184(6): 1249-50.
79. Nelson DM. Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996; 17(7): 387-91.
80. Endo H, Okamoto A et al. Frequent apoptosis in placental villi from pregnancies complicated with intrauterine growth restriction and without maternal symptoms. Int J Mol Med 2005; 16(1): 79-84.
81. Heazell AE, Brown LM et al. Expression of oncoproteins p53 and Mdm2 within trophoblast of normal and pre-eclamptic pregnancies. J Soc Gynecol Investig 2005; 12(2 Suppl): 362A.
82. Heazell AE, Brown LM et al. Expression of Oncoproteins p53, BAK and p21 in normal pregnancies and those complicated by pre-eclampsia. Placenta 2005; 26: A59.
83. Qiao S, Nagasaka T et al. p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole. Placenta 1998; 19(5-6): 361-9.
84. Gruslin A, Qiu Q et al. X-linked inhibitor of apoptosis protein expression and the regulation of apoptosis during human placental development. Biol Reprod 2001; 64(4): 1264-72.
85. Ka H, Hunt JS. Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol 2003; 163(2): 413-22.
86. Levy R, Smith SD et al. Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol 2002; 186(5): 1056-61.
87. Prives C, Hall PA. The p53 pathway. J Pathol 1999; 187(1): 112-26.
88. Rajakumar A, Doty K et al. Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae. Placenta 2003; 24(2-3): 199-208.
89. Rajakumar A, Brandon HM et al. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 2004; 25(10): 763-9.
90. Huppertz B, Kingdom J et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 2003; 24(2-3): 181-90.
91. Johansen M, Redman CW et al. Trophoblast deportation in human pregnancy - its relevance for pre-eclampsia. Placenta 1999; 20(7): 531-9.
92. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308(5728): 1592-4.
93. Roberts JM, Taylor RN et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161(5): 1200-4.
94. Hayman R, Brockelsby J et al. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Investig 1999; 6(1): 3-10.
95. Busse R, Edwards G et al. EDHF: bringing the concepts together. Trends Pharmacol Sci 2002; 23(8): 374-80.
96. Kenny LC, Baker PN et al. Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and preeclampsia. Clin Sci (Lond) 2002; 103(1): 67-73.
97. Hefler LA, Tempfer CB et al. Placental expression and serum levels of cytokeratin-18 are increased in women with preeclampsia. J Soc Gynecol Investig 2001; 8(3): 169-73.
98. Cockell AP, Learmont JG et al. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 1997; 104(2): 235-40.
99. Gupta AK, Rusterholz C et al. A comparative study of the effect of three different syncytiotrophoblast microparticles preparations on endothelial cells. Placenta 2005; 26(1): 59-66.
100. Sargent IL, Germain SJ et al. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol 2003; 59(2): 153-60.
101. Shibata E, Rajakumar A et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005; 90(8): 4895-903.
102. Maynard SE, Min JY et al. Excess placental soluble fms-l ike tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111(5): 649-58.
103. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the “chicken-and-egg” question. Endocrinology 2004; 145(11): 4835-7.
104. Nagamatsu T, Fujii T et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004; 145(11): 4838-45.
105. Myers JE, Hart S et al. There is no single circulating factor in pre-eclampsia (toxaemia). B J Obstet Gynaecol 2005; 112: 1450.